{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:39:22Z","timestamp":1791488362397,"version":"4.3.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T00:00:00Z","timestamp":1539216000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81472645"],"award-info":[{"award-number":["81472645"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671637"],"award-info":[{"award-number":["81671637"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4844-1","type":"journal-article","created":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T09:56:24Z","timestamp":1539251784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Post-transcriptional regulation of cancer\/testis antigen MAGEC2 expression by TRIM28 in tumor cells"],"prefix":"10.1186","volume":"18","author":[{"given":"Xiao","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengli","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongtian","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0977-0354","authenticated-orcid":false,"given":"Yanhui","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,11]]},"reference":[{"issue":"8","key":"4844_CR1","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/nrc1669","volume":"5","author":"AJ Simpson","year":"2005","unstructured":"Simpson AJ, Caballero OL, Jungbluth A, Chen Y-T, Old LJ. Cancer\/testis antigens, gametogenesis and cancer. Nat Rev Cancer. 2005;5(8):615\u201325.","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"4844_CR2","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1111\/j.1349-7006.2009.01303.x","volume":"100","author":"OL Caballero","year":"2009","unstructured":"Caballero OL, Chen YT. Cancer\/testis (CT) antigens: potential targets for immunotherapy. Cancer Sci. 2009;100(11):2014\u201321.","journal-title":"Cancer Sci"},{"issue":"4","key":"4844_CR3","first-page":"395","volume":"12","author":"S Ghafouri-Fard","year":"2009","unstructured":"Ghafouri-Fard S, Modarressi M-H. Cancer-testis antigens: potential targets for cancer immunotherapy. Arch Iran Med. 2009;12(4):395\u2013404.","journal-title":"Arch Iran Med"},{"issue":"7","key":"4844_CR4","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1200\/JCO.2010.32.2537","volume":"29","author":"PF Robbins","year":"2011","unstructured":"Robbins PF, Morgan RA, Feldman SA, Yang JC, Sherry RM, Dudley ME, Wunderlich JR, Nahvi AV, Helman LJ, Mackall CL, et al. Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1. J Clin Oncol. 2011;29(7):917\u201324.","journal-title":"J Clin Oncol"},{"issue":"2","key":"4844_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/CJI.0b013e3182829903","volume":"36","author":"RA Morgan","year":"2013","unstructured":"Morgan RA, Chinnasamy N, Abate-Daga D, Gros A, Robbins PF, Zheng Z, Dudley ME, Feldman SA, Yang JC, Sherry RM, et al. Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy. J Immunother. 2013;36(2):133\u201351.","journal-title":"J Immunother"},{"issue":"suppl 1","key":"4844_CR6","doi-asserted-by":"publisher","first-page":"D816","DOI":"10.1093\/nar\/gkn673","volume":"37","author":"LG Almeida","year":"2009","unstructured":"Almeida LG, Sakabe NJ, Silva MCC, Mundstein AS, Cohen T, Chen Y-T, Chua R, Gurung S, Gnjatic S, Jungbluth AA. CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens. Nucleic Acids Res. 2009;37(suppl 1):D816\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"4844_CR7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/1471-2164-8-129","volume":"8","author":"BJ Stevenson","year":"2007","unstructured":"Stevenson BJ, Iseli C, Panji S, Zahn-Zabal M, Hide W, Old LJ, Simpson AJ, Jongeneel CV. Rapid evolution of cancer\/testis genes on the X chromosome. BMC Genomics. 2007;8(1):129.","journal-title":"BMC Genomics"},{"issue":"1","key":"4844_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/1097-0215(20000701)87:1<55::AID-IJC8>3.0.CO;2-J","volume":"87","author":"S Lucas","year":"2000","unstructured":"Lucas S, De Plaen E, Boon T. MAGE-B5, MAGE-B6, MAGE-C2, and MAGE-C3: four new members of the MAGE family with tumor-specific expression. Int J Cancer. 2000;87(1):55\u201360.","journal-title":"Int J Cancer"},{"issue":"8","key":"4844_CR9","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1097\/01.LAB.0000080605.73839.96","volume":"83","author":"B Li","year":"2003","unstructured":"Li B, Qian X-P, Pang X-W, Zou W-Z, Wang Y-P, Wu H-Y, Chen W-F. HCA587 antigen expression in normal tissues and cancers: correlation with tumor differentiation in hepatocellular carcinoma. Lab Investig. 2003;83(8):1185\u201392.","journal-title":"Lab Investig"},{"issue":"2","key":"4844_CR10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.lungcan.2006.12.004","volume":"56","author":"JR Tsai","year":"2007","unstructured":"Tsai JR, Chong IW, Chen YH, Yang MJ, Sheu CC, Chang HC, Hwang JJ, Hung JY, Lin SR. Differential expression profile of MAGE family in non-small-cell lung cancer. Lung Cancer. 2007;56(2):185\u201392.","journal-title":"Lung Cancer"},{"key":"4844_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ceb.2015.08.002","volume":"37","author":"JL Weon","year":"2015","unstructured":"Weon JL, Potts PR. The MAGE protein family and cancer. Curr Opin Cell Biol. 2015;37:1\u20138.","journal-title":"Curr Opin Cell Biol"},{"issue":"6","key":"4844_CR12","doi-asserted-by":"publisher","first-page":"e21418","DOI":"10.1371\/journal.pone.0021418","volume":"6","author":"A Curioni-Fontecedro","year":"2011","unstructured":"Curioni-Fontecedro A, Nuber N, Mihic-Probst D, Seifert B, Soldini D, Dummer R, Knuth A, van den Broek M, Moch H. Expression of MAGE-C1\/CT7 and MAGE-C2\/CT10 predicts lymph node metastasis in melanoma patients. PLoS One. 2011;6(6):e21418.","journal-title":"PLoS One"},{"issue":"1","key":"4844_CR13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s10549-014-2915-9","volume":"145","author":"F Yang","year":"2014","unstructured":"Yang F, Zhou X, Miao X, Zhang T, Hang X, Tie R, Liu N, Tian F, Wang F, Yuan J. MAGEC2, an epithelial-mesenchymal transition inducer, is associated with breast cancer metastasis. Breast Cancer Res Treat. 2014;145(1):23\u201332.","journal-title":"Breast Cancer Res Treat"},{"key":"4844_CR14","doi-asserted-by":"crossref","unstructured":"Hao J, Shen R, Li Y, Zhang Y, Yin Y. Cancer-testis antigen MAGE-C2 binds Rbx1 and inhibits ubiquitin ligase-mediated turnover of cyclin E. Oncotarget. 2015;6(39):42028.","DOI":"10.18632\/oncotarget.5973"},{"issue":"3","key":"4844_CR15","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/jid.2012.355","volume":"133","author":"N Bhatia","year":"2013","unstructured":"Bhatia N, Xiao TZ, Rosenthal KA, Siddiqui IA, Thiyagarajan S, Smart B, Meng Q, Zuleger CL, Mukhtar H, Kenney SC. MAGE-C2 promotes growth and tumorigenicity of melanoma cells, phosphorylation of KAP1, and DNA damage repair. J Investig Dermatol. 2013;133(3):759\u201367.","journal-title":"J Investig Dermatol"},{"issue":"6","key":"4844_CR16","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.molcel.2010.08.029","volume":"39","author":"JM Doyle","year":"2010","unstructured":"Doyle JM, Gao J, Wang J, Yang M, Potts PR. MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases. Mol Cell. 2010;39(6):963\u201374.","journal-title":"Mol Cell"},{"issue":"11","key":"4844_CR17","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1038\/onc.2016.314","volume":"36","author":"X Song","year":"2017","unstructured":"Song X, Hao J, Wang J, Guo C, Wang Y, He Q, Tang H, Qin X, Li Y, Zhang Y, et al. The cancer\/testis antigen MAGEC2 promotes amoeboid invasion of tumor cells by enhancing STAT3 signaling. Oncogene. 2017;36(11):1476\u201386.","journal-title":"Oncogene"},{"issue":"6","key":"4844_CR18","doi-asserted-by":"publisher","first-page":"656","DOI":"10.7150\/jca.13674","volume":"7","author":"X Song","year":"2016","unstructured":"Song X, Song W, Wang Y, Wang J, Li Y, Qian X, Pang X, Zhang Y, Yin Y. MicroRNA-874 functions as a tumor suppressor by targeting Cancer\/testis antigen HCA587\/MAGE-C2. J Cancer. 2016;7(6):656\u201363.","journal-title":"J Cancer"},{"issue":"16","key":"4844_CR19","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1101\/gad.10.16.2067","volume":"10","author":"JR Friedman","year":"1996","unstructured":"Friedman JR, Fredericks WJ, Jensen DE, Speicher DW, Huang X-P, Neilson EG, Rauscher F. KAP-1, a novel corepressor for the highly conserved KRAB repression domain. Genes Dev. 1996;10(16):2067\u201378.","journal-title":"Genes Dev"},{"issue":"26","key":"4844_CR20","doi-asserted-by":"publisher","first-page":"15299","DOI":"10.1073\/pnas.93.26.15299","volume":"93","author":"S-S Kim","year":"1996","unstructured":"Kim S-S, Chen Y-M, O\u2019Leary E, Witzgall R, Vidal M, Bonventre JV. A novel member of the RING finger family, KRIP-1, associates with the KRAB-A transcriptional repressor domain of zinc finger proteins. Proc Natl Acad Sci. 1996;93(26):15299\u2013304.","journal-title":"Proc Natl Acad Sci"},{"issue":"24","key":"4844_CR21","doi-asserted-by":"publisher","first-page":"4859","DOI":"10.1093\/nar\/24.24.4859","volume":"24","author":"P Moosmann","year":"1996","unstructured":"Moosmann P, Georgiev O, Le Douarin B, Bourquin J-P, Schaffner W. Transcriptional repression by RING finger protein TIF1\u03b2 that interacts with the KRAB repressor domain of KOX1. Nucleic Acids Res. 1996;24(24):4859\u201367.","journal-title":"Nucleic Acids Res"},{"issue":"17","key":"4844_CR22","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1101\/gad.302904","volume":"18","author":"F Cammas","year":"2004","unstructured":"Cammas F, Herzog M, Lerouge T, Chambon P, Losson R. Association of the transcriptional corepressor TIF1beta with heterochromatin protein 1 (HP1): an essential role for progression through differentiation. Genes Dev. 2004;18(17):2147\u201360.","journal-title":"Genes Dev"},{"issue":"7","key":"4844_CR23","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/j.1432-0436.2007.00166.x","volume":"75","author":"F Cammas","year":"2007","unstructured":"Cammas F, Janoshazi A, Lerouge T, Losson R. Dynamic and selective interactions of the transcriptional corepressor TIF1 beta with the heterochromatin protein HP1 isotypes during cell differentiation. Differentiation. 2007;75(7):627\u201337.","journal-title":"Differentiation"},{"issue":"11","key":"4844_CR24","doi-asserted-by":"publisher","first-page":"4561","DOI":"10.1096\/fj.12-206177","volume":"26","author":"FR Santoni de Sio","year":"2012","unstructured":"Santoni de Sio FR, Barde I, Offner S, Kapopoulou A, Corsinotti A, Bojkowska K, Genolet R, Thomas JH, Luescher IF, Pinschewer D, et al. KAP1 regulates gene networks controlling T-cell development and responsiveness. FASEB J. 2012;26(11):4561\u201375.","journal-title":"FASEB J"},{"issue":"20","key":"4844_CR25","doi-asserted-by":"publisher","first-page":"4675","DOI":"10.1182\/blood-2011-12-401117","volume":"119","author":"FR Santoni de Sio","year":"2012","unstructured":"Santoni de Sio FR, Massacand J, Barde I, Offner S, Corsinotti A, Kapopoulou A, Bojkowska K, Dagklis A, Fernandez M, Ghia P, et al. KAP1 regulates gene networks controlling mouse B-lymphoid cell differentiation and function. Blood. 2012;119(20):4675\u201385.","journal-title":"Blood"},{"issue":"6","key":"4844_CR26","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/ni.2293","volume":"13","author":"S Chikuma","year":"2012","unstructured":"Chikuma S, Suita N, Okazaki IM, Shibayama S, Honjo T. TRIM28 prevents autoinflammatory T cell development in vivo. Nat Immunol. 2012;13(6):596\u2013603.","journal-title":"Nat Immunol"},{"issue":"3","key":"4844_CR27","doi-asserted-by":"publisher","first-page":"308","DOI":"10.4331\/wjbc.v5.i3.308","volume":"5","author":"CT Cheng","year":"2014","unstructured":"Cheng CT, Kuo CY, Ann DK. KAPtain in charge of multiple missions: emerging roles of KAP1. World J Biol Chem. 2014;5(3):308\u201320.","journal-title":"World J Biol Chem"},{"issue":"2","key":"4844_CR28","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1158\/0008-5472.CAN-14-1561","volume":"75","author":"JB Addison","year":"2015","unstructured":"Addison JB, Koontz C, Fugett JH, Creighton CJ, Chen D, Farrugia MK, Padon RR, Voronkova MA, McLaughlin SL, Livengood RH, et al. KAP1 promotes proliferation and metastatic progression of breast cancer cells. Cancer Res. 2015;75(2):344\u201355.","journal-title":"Cancer Res"},{"issue":"3","key":"4844_CR29","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1245\/s10434-009-0795-8","volume":"17","author":"T Yokoe","year":"2010","unstructured":"Yokoe T, Toiyama Y, Okugawa Y, Tanaka K, Ohi M, Inoue Y, Mohri Y, Miki C, Kusunoki M. KAP1 is associated with peritoneal Carcinomatosis in gastric Cancer. Ann Surg Oncol. 2010;17(3):821\u20138.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"4844_CR30","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s10147-016-0979-8","volume":"21","author":"YY Wang","year":"2016","unstructured":"Wang YY, Jiang JX, Li Q, Ma H, Xu ZG, Gao Y. KAP1 is overexpressed in hepatocellular carcinoma and its clinical significance. Int J Clin Oncol. 2016;21(5):927\u201333.","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"4844_CR31","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3390\/ijms16010363","volume":"16","author":"Y Cui","year":"2014","unstructured":"Cui Y, Yang S, Fu X, Feng J, Xu S, Ying G. High levels of KAP1 expression are associated with aggressive clinical features in ovarian cancer. Int J Mol Sci. 2014;16(1):363\u201377.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4844_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11060-015-1897-8","volume":"126","author":"ZX Qi","year":"2016","unstructured":"Qi ZX, Cai JJ, Chen LC, Yue Q, Gong Y, Yao Y, Mao Y. TRIM28 as an independent prognostic marker plays critical roles in glioma progression. J Neuro-Oncol. 2016;126(1):19\u201326.","journal-title":"J Neuro-Oncol"},{"key":"4844_CR33","first-page":"7","volume":"6","author":"R Zhuang","year":"2006","unstructured":"Zhuang R, Zhu Y, Fang L, Liu XS, Tian Y, Chen LH, Ouyang WM, Xu XG, Jian JL, Gure AO, et al. Generation of monoclonal antibodies to cancer\/testis (CT) antigen CT10\/MAGE-C2. Cancer Immun. 2006;6:7.","journal-title":"Cancer Immun"},{"issue":"4","key":"4844_CR34","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.bbrc.2014.05.078","volume":"449","author":"J Hao","year":"2014","unstructured":"Hao J, Shen R, Li Y, Zhang Y, Yin Y. Cancer-testis antigen HCA587\/MAGE-C2 interacts with BS69 and promotes its degradation in the ubiquitin-proteasome pathway. Biochem Biophys Res Commun. 2014;449(4):386\u201391.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"4844_CR35","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/bjc.2012.324","volume":"107","author":"DC Christoph","year":"2012","unstructured":"Christoph DC, Kasper S, Gauler TC, Loesch C, Engelhard M, Theegarten D, Poettgen C, Hepp R, Peglow A. Loewendick H et al: betaV-tubulin expression is associated with outcome following taxane-based chemotherapy in non-small cell lung cancer. Br J Cancer. 2012;107(5):823\u201330.","journal-title":"Br J Cancer"},{"issue":"12","key":"4844_CR36","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1111\/cas.13082","volume":"107","author":"J Wang","year":"2016","unstructured":"Wang J, Song X, Guo C, Wang Y, Yin Y. Establishment of MAGEC2-knockout cells and functional investigation of MAGEC2 in tumor cells. Cancer Sci. 2016;107(12):1888\u201397.","journal-title":"Cancer Sci"},{"issue":"7","key":"4844_CR37","first-page":"1766","volume":"54","author":"J Weber","year":"1994","unstructured":"Weber J, Salgaller M, Samid D, Johnson B, Herlyn M, Lassam N, Treisman J, Rosenberg SA. Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2\u2032-deoxycytidine. Cancer Res. 1994;54(7):1766\u201371.","journal-title":"Cancer Res"},{"issue":"2","key":"4844_CR38","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/ijc.23966","volume":"124","author":"MO Riener","year":"2009","unstructured":"Riener MO, Wild PJ, Soll C, Knuth A, Jin B, Jungbluth A, Hellerbrand C, Clavien PA, Moch H, Jochum W. Frequent expression of the novel cancer testis antigen MAGE-C2\/CT-10 in hepatocellular carcinoma. Int J Cancer. 2009;124(2):352\u20137.","journal-title":"Int J Cancer"},{"issue":"15","key":"4844_CR39","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1007\/s00018-009-0030-6","volume":"66","author":"E Knecht","year":"2009","unstructured":"Knecht E, Aguado C, Carcel J, Esteban I, Esteve JM, Ghislat G, Moruno JF, Vidal JM, Saez R. Intracellular protein degradation in mammalian cells: recent developments. Cell Mol Life Sci. 2009;66(15):2427\u201343.","journal-title":"Cell Mol Life Sci"},{"issue":"10","key":"4844_CR40","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1002\/ijc.25911","volume":"129","author":"W Ma","year":"2011","unstructured":"Ma W, Vigneron N, Chapiro J, Stroobant V, Germeau C, Boon T, Coulie PG, Van den Eynde BJ. A MAGE-C2 antigenic peptide processed by the immunoproteasome is recognized by cytolytic T cells isolated from a melanoma patient after successful immunotherapy. Int J Cancer. 2011;129(10):2427\u201334.","journal-title":"Int J Cancer"},{"issue":"10","key":"4844_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047219","volume":"7","author":"J Chen","year":"2012","unstructured":"Chen J, Zhang L, Wen W, Hao J, Zeng P, Qian X, Zhang Y, Yin Y. Induction of HCA587-specific antitumor immunity with HCA587 protein formulated with CpG and ISCOM in mice. PLoS One. 2012;7(10):e47219.","journal-title":"PLoS One"},{"issue":"4","key":"4844_CR42","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3727\/096504014X13887748696789","volume":"21","author":"L Zhang","year":"2014","unstructured":"Zhang L, Chen J, Song X, Wen W, Li Y, Zhang Y, Yin Y. Cancer\/testis antigen HCA587-derived long peptide vaccine generates potent immunologic responses and antitumor effects in mouse model. Oncol Res. 2014;21(4):193\u2013200.","journal-title":"Oncol Res"},{"issue":"8","key":"4844_CR43","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1111\/j.1349-7006.2011.01986.x","volume":"102","author":"W Wen","year":"2011","unstructured":"Wen W, Zhang L, Peng J, Chen J, Hao J, Li X, Qian X, Zeng P, Zhang Y, Yin Y. Identification of promiscuous HLA-DR-restricted CD4(+) T-cell epitopes on the cancer-testis antigen HCA587. Cancer Sci. 2011;102(8):1455\u201361.","journal-title":"Cancer Sci"},{"issue":"30","key":"4844_CR44","doi-asserted-by":"publisher","first-page":"26267","DOI":"10.1074\/jbc.R111.252569","volume":"286","author":"S Iyengar","year":"2011","unstructured":"Iyengar S, Farnham PJ. KAP1 protein: an enigmatic master regulator of the genome. J Biol Chem. 2011;286(30):26267\u201376.","journal-title":"J Biol Chem"},{"issue":"4","key":"4844_CR45","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.cell.2015.01.034","volume":"160","author":"CT Pineda","year":"2015","unstructured":"Pineda CT, Ramanathan S, Fon Tacer K, Weon JL, Potts MB, Ou YH, White MA, Potts PR. Degradation of AMPK by a cancer-specific ubiquitin ligase. Cell. 2015;160(4):715\u201328.","journal-title":"Cell"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4844-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-4844-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4844-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T19:12:11Z","timestamp":1570734731000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4844-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,11]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4844"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4844-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,11]]},"assertion":[{"value":"9 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the samples were collected with patient\u2019s informed consent after approval from the Ethics Review Committee of Peking University of Health Science Center. No ethics approval was required for the use of human cell lines in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"971"}}